Look to these tools to improve your AI coding practices and the quality, security, and reliability of your AI-generated code.

Mida chairman Tengku Datuk Seri Zafrul Abdul Aziz. KUALA LUMPUR: The misconception that data centres (DCs) only generate jobs is misplaced as they bring about wider economic benefits beyond direct ...

This extension for StarUML(http://staruml.io) support to generate Java code from UML model and to reverse Java code to UML model. Install this extension from ...

Anyone can code using AI. But it might come with a hidden cost. Limited time: Save 25% on NBC News subscription Get exclusive reporting, live Q&As and ad-free reading. Over the past year, AI systems ...

The entire source code for Anthropic’s Claude Code command line interface application (not the models themselves) has been leaked and disseminated, apparently due ...

The Java ecosystem has historically been blessed with great IDEs to work with, including NetBeans, Eclipse and IntelliJ from JetBrains. However, in recent years Microsoft's Visual Studio Code editor ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

With Claude enjoying a moment of newfound popularity among regular people, Anthropic is previewing an update designed to make its chatbot better at explaining some concepts. Starting today, Claude can ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines has earmarked $300 million of its IPO funds to complete a pair of phase 3 asthma trials for its anti-TSLP antibody GB-0895. (Fabrice Cabaud/Stock/Getty Images Plus) ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...